Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic mutations that drive disease.
The system predicts how mutations disrupt gene regulation, affecting when and where genes activate.
AlphaGenome can analyse up to one million DNA letters at once using human and mouse genetic data.
Researchers say it could clarify causes of cancer, heart disease, autoimmune disorders, and mental health conditions.
The tool may also support gene therapy design by enabling precise control of gene activity.
Independent scientists called AlphaGenome a major step toward understanding the non-coding genome.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
